Skip to search formSkip to main contentSkip to account menu

Cytostasan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
The pharmacokinetics of bendamustine, (1; Cytostasan), an alkylating antineoplastic agent of the N-lost group, was investigated… 
1991
1991
Biliary excretion of bendamustin (Cytostasan, 5-[bis(2-chloroethyl)amino]-i-methylbenzimidazole-2-butyric acid; 1) and its… 
1991
1991
Remission rates of 30-50% can be obtained using different cytostatic combinations in second line therapy of metastatic breast… 
1991
1991
The synthesis of the methylester of (5-[Bis(2-chlorethyl)amino]-1-methyl-benzimidazolyl-(2))ethanolic acid (4) has been described… 
1989
1989
Remission rate of 30-50% can be obtained by different cytostatic combinations in second-line-therapy of the metastasized breast… 
1984
1984
In MOPP-resistant patients with Hodgkin-lymphoma stage III B and IV the well known ABVD-protocol was compared with the DBVCy… 
1976
1976
This presentation describes the action of Cytostasan, a nitrogen mustard compound of benzimidazole, on reproduction and embryonic…